Terms: = Liver cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK
535 results:
1. The long-term efficacy of imatinib with hepatic resection or other local treatment for gastrointestinal stromal tumours liver metastases: a retrospective cohort study.
Wen H; Huang Y; Huang S; Xiao H; Xie W; Zhou Q; Tan L; Ding Y; Liu X; Yu Y; Song Z; Shen S; Chen Z; Zhang X
Int J Surg; 2024 Apr; 110(4):2151-2161. PubMed ID: 38619177
[TBL] [Abstract] [Full Text] [Related]
2. Development of crizotinib-associated renal cyst in a non-small cell lung cancer patient with alk fusion: a case report and review of the literature.
Zhang P; Xu J; Wu Q; Qian J; Wang S
Diagn Pathol; 2024 Apr; 19(1):58. PubMed ID: 38616252
[TBL] [Abstract] [Full Text] [Related]
3. Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients.
Tadokoro T; Nomura T; Fujita K; Manabe T; Takuma K; Nakahara M; Oura K; Mimura S; Tani J; Morishita A; Kobara H; Ono M; Masaki T
BMC Gastroenterol; 2024 Apr; 24(1):123. PubMed ID: 38561671
[TBL] [Abstract] [Full Text] [Related]
4. Sarcomatoid hepatocellular carcinoma: A case report and review of the literature.
Hu C; Zhao M; Wei Q; Chen Z; Zhao B
Medicine (Baltimore); 2024 Mar; 103(13):e37641. PubMed ID: 38552058
[TBL] [Abstract] [Full Text] [Related]
5. Differential expression of circular RNAs in human umbilical cord mesenchymal stem cells treated with icariin.
Liu X; Chu X; Li L; Man S; Wang L; Bian Y; Zhou H
Medicine (Baltimore); 2024 Mar; 103(12):e37549. PubMed ID: 38517991
[TBL] [Abstract] [Full Text] [Related]
6. Real-World Treatment Patterns and Clinical Outcomes After Platinum-Doublet Chemotherapy and Immunotherapy in Metastatic Non-Small Cell Lung cancer: A Multiregional Chart Review in the United States, Europe, and Japan.
Leal TA; Dasgupta A; Latremouille-Viau D; Rossi C; Rai P; Barlesi F; Liu SV
JCO Glob Oncol; 2024 Mar; 10():e2300483. PubMed ID: 38484195
[TBL] [Abstract] [Full Text] [Related]
7. Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma: The Effectiveness of Different Particle Sizes in Downstaging and Bridging in Living Donor liver Transplantation.
Lim WX; Sim KS; Chen CL; Ou HY; Yu CY; Cheng YF
Transplant Proc; 2024 Apr; 56(3):596-601. PubMed ID: 38472083
[TBL] [Abstract] [Full Text] [Related]
8. Targeting alk averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma.
Liu C; Zhou C; Xia W; Zhou Y; Qiu Y; Weng J; Zhou Q; Chen W; Wang YN; Lee HH; Wang SC; Kuang M; Yu D; Ren N; Hung MC
Nat Commun; 2024 Feb; 15(1):1009. PubMed ID: 38307859
[TBL] [Abstract] [Full Text] [Related]
9. The timing phase affected the inconsistency of APHE subtypes of liver observations in patients at risk for HCC on the multi-hepatic arterial phase imaging.
Jiang J; Yang D; Yang Z; Han X; Xu L; Wang Y; Wang X; Yang Z; Xu H
Abdom Radiol (NY); 2024 Apr; 49(4):1092-1102. PubMed ID: 38195799
[TBL] [Abstract] [Full Text] [Related]
10. Case report: Successful sequential therapy of crizotinb and entrectinib in ROS1-positive non-small-cell lung cancer with brain metastasis in later-settings.
Dong W; Zhuge J; Yu P; Liu K; Yang M; Wang H
Medicine (Baltimore); 2023 Dec; 102(51):e36591. PubMed ID: 38134118
[TBL] [Abstract] [Full Text] [Related]
11. The effect of switch therapy to tenofovir versus entecavir maintenance on recurrence of hepatocellular carcinoma after surgery (SWITE): study protocol for a randomized controlled trial.
Peng W; Yi M; Qi X; Qi W; Li C; Wen T
Trials; 2023 Dec; 24(1):781. PubMed ID: 38042834
[TBL] [Abstract] [Full Text] [Related]
12. Carvedilol Plus NUC for Patients With HBV-Compensated Cirrhosis Under Virological Suppression: A Randomized Open-Label Trial.
Wang B; Zhou J; Wu X; Sun Y; Li L; Li P; Li M; Jiang W; Xu M; Feng B; Xu X; Cheng J; Xie W; Han T; Wang X; Li H; Piao H; Zhao X; Chen S; Meng T; Guan Q; Meng F; Kong Y; Ou X; Jia J; You H
Am J Gastroenterol; 2024 Apr; 119(4):700-711. PubMed ID: 37929952
[TBL] [Abstract] [Full Text] [Related]
13. Head-to-head comparison of
Zhang J; Jiang S; Li M; Xue H; Zhong X; Li S; Peng H; Liang J; Liu Z; Rao S; Chen H; Cao Z; Gong Y; Chen G; Zhang R; Zhang L
Cancer Imaging; 2023 Oct; 23(1):106. PubMed ID: 37899452
[TBL] [Abstract] [Full Text] [Related]
14. Combination of GT90001 and nivolumab in patients with advanced hepatocellular carcinoma: a multicenter, single-arm, phase 1b/2 study.
Hsu C; Chang YF; Yen CJ; Xu YW; Dong M; Tong YZ
BMC Med; 2023 Oct; 21(1):395. PubMed ID: 37858184
[TBL] [Abstract] [Full Text] [Related]
15. Selective internal radiation therapy using yttrium-90 microspheres for treatment of localized and locally advanced intrahepatic cholangiocarcinoma.
Yu Q; Ungchusri E; Pillai A; Liao CY; Baker T; Fung J; DiSabato D; Zhang M; Liao C; Van Ha T; Ahmed O
Eur Radiol; 2024 Apr; 34(4):2374-2383. PubMed ID: 37812295
[TBL] [Abstract] [Full Text] [Related]
16. Age-Dependent Female Survival Advantage in Hepatocellular Carcinoma: A Multicenter Cohort Study.
Pang C; Li JM; Wang Z; Luo YC; Cheng ZG; Han ZY; Liu FY; Yu XL; Liang F; Xi HQ; Zheng RQ; Cheng W; Wei Q; Yu SY; Li QY; He GZ; Yu J; Liang P
Clin Gastroenterol Hepatol; 2024 Feb; 22(2):305-314. PubMed ID: 37659766
[TBL] [Abstract] [Full Text] [Related]
17. Small extrachromosomal circular DNAs as biomarkers for multi-cancer diagnosis and monitoring.
Luo X; Zhang L; Cui J; An Q; Li H; Zhang Z; Sun G; Huang W; Li Y; Li C; Jia W; Zou L; Zhao G; Xiao F
Clin Transl Med; 2023 Sep; 13(9):e1393. PubMed ID: 37649244
[TBL] [Abstract] [Full Text] [Related]
18. Late-stage presentation with decompensated cirrhosis is alarmingly common but successful etiologic therapy allows for favorable clinical outcomes.
Schwarz M; Schwarz C; Burghart L; Pfisterer N; Bauer D; Hübl W; Mandorfer M; Gschwantler M; Reiberger T
PLoS One; 2023; 18(8):e0290352. PubMed ID: 37616205
[TBL] [Abstract] [Full Text] [Related]
19. Discovery of novel arylamide derivatives containing piperazine moiety as inhibitors of tubulin polymerisation with potent liver cancer inhibitory activity.
Shi XY; Jiao H; Zhang JK; Tian XY; Guo DF; Gao J; Jia MQ; Song J; Zhang SY; Fu XJ; Tang HW
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2237701. PubMed ID: 37489043
[TBL] [Abstract] [Full Text] [Related]
20. alk Inhibitor Treatment Patterns and Outcomes in Real-World Patients with alk-Positive Non-Small-Cell Lung cancer: A Retrospective Cohort Study.
Wang M; Slatter S; Sussell J; Lin CW; Ogale S; Datta D; Butte AJ; Bazhenova L; Rudrapatna VA
Target Oncol; 2023 Jul; 18(4):571-583. PubMed ID: 37341856
[TBL] [Abstract] [Full Text] [Related]
[Next]
